Oxford Ledge
Search
No licensed closing price on file for RVMD. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
Revolution Medicines, Inc. (NASDAQ: RVMD) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-19 18:32 UTC.
The company is developing cancer therapies that face competition from established pharmaceutical companies, biotechnology firms, and academic institutions with greater resources and existing approved products. Competition limits patient enrollment in the company's clinical trials, as patients may choose approved therapies or enroll in competitor trials instead, and qualified clinical investigators are shared across multiple companies at the same trial sites.
Summarized from Revolution Medicines, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
| Valuation | |
| Return on equity | -23.89% |
The company is developing cancer therapies that face competition from established pharmaceutical companies, biotechnology firms, and academic institutions with greater resources and existing approved products.
Revolution Medicines, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-22. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-19 18:32 UTC. This page is also available as JSON at /api/data?ticker=RVMD and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for RVMD and 5,000+ tickers.
Create a free account — keep RVMDGET /api/data?ticker=RVMD
This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt